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Objective.— The aim of this prospective study was to evaluate the contribution of an ini-
tially shortened deceleration time of mitral inﬂow E velocity (E-wave DT) to predict survival
in patients with left-ventricular (LV) systolic dysfunction in atrial ﬁbrillation (AF) and in sinus
rhythm (SR).
Background.— To date, few data are available concerning the prognostic value of Doppler mitral
proﬁle in patients with AF, particularly in the presence of LV systolic dysfunction.
Methods.— We studied the outcome of 140 consecutive patients with LV ejection fraction less
than 40%. Complete history, physical examination and echocardiography were performed.
Results.— Chronic AF was present in 40 (29%) patients. Over a mean follow-up of 25± 11
months, 54 (39%) patients died, 18 in the AF group and 36 in the SR group. Ejection frac-
tion was similar in the two groups (31% versus 32%, respectively). Survival curves indicated a
signiﬁcantly poorer prognosis for shortened E-wave DT less than 150ms in the AF group and in
the SR group (both p≤ 0.01). Using multivariable Cox analysis, shortened E-wave DT was identi-
ﬁed as an independent predictor of mortality in the AF group (exponential of coefﬁcient: 0.97;
chi-square: 5.82; p = 0.01) and in the SR group (exponential of coefﬁcient: 0.98; chi-square:
5.82; p = 0.001).
Abbreviations: AF, atrial ﬁbrillation; SR, sinus rhythm; E-wave DT, mitral inﬂow E velocity deceleration time; LV, left ventricular;
CHF, congestive heart failure.
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Conclusion.— In patients with LV systolic dysfunction, a shortened deceleration time E-wave
on Doppler examination appears to predict a similar poor prognosis in patients with AF as with
SR.









Justiﬁcation.— À ce jour, peu de données sont disponibles concernant la valeur pronostique du
proﬁl transmitral chez les patients en ﬁbrillation auriculaire, en particulier en présence d’une
dysfonction systolique ventriculaire gauche.
Objectif.— L’objectif de cette étude prospective était d’évaluer la contribution d’un raccour-
cissement du temps de décélération mesuré sur l’onde E du ﬂux transmitral (onde E/DT) pour
prédire la survie chez les patients ayant une dysfonction systolique ventriculaire gauche, en
ﬁbrillation auriculaire et en rythme sinusal.
Méthode.— Nous avons étudié le devenir de 140 patients consécutifs, ayant une fraction
d’éjection ventriculaire gauche inférieure à 40%. Les antécédents médicaux, l’examen physique
et les données échographiques ont été réalisés.
Résultats.— La ﬁbrillation auriculaire chronique était présente chez 40 patients (29 %), avec un
suivi moyen de 25± 11 mois, 54 patients (39 %) sont décédés, visibles dans le groupe ﬁbrillation
auriculaire et 36 dans le groupe rythme sinusal. La fraction d’éjection ventriculaire gauche était
similaire dans les deux groupes (31 % versus 32 %). Les courbes actuarielles de survie montraient
un pronostic plus altéré chez les patients ayant un temps de décélération de l’onde E inférieur à
150ms dans le groupe ﬁbrillation auriculaire et dans le groupe rythme sinusal (p < 0,01 dans les
deux cas). En utilisant l’analyse multivariée selon un modèle de Cox, un temps de décélération
raccourci de l’onde E était un prédicteur indépendant de la mortalité dans le groupe ﬁbrillation
auriculaire (coefﬁcient de l’exponentiel ; 0,97 ; Khi2 : 5,82 ; p = 0.01) et dans le groupe rythme
sinusal (coefﬁcient de l’exponentiel : 0,98 ; Khi2 : 5,82 ; p = 0,001).
Conclusion.— Chez les patients ayant une dysfonction systolique ventriculaire gauche, un temps
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ntroduction
everal studies have attempted to identify prognostic fac-
ors for patients with heart failure and left-ventricular (LV)
ystolic dysfunction [1—6]. It is now recognized that Doppler
chocardiography, including both systolic and diastolic
arameters, provides information regarding the prognosis
n this population [1—6]. However, patients with atrial ﬁb-
illation (AF) were generally excluded from these studies,
imiting the applicability of these echocardiographic param-
ters to patients in sinus rhythm (SR). Nevertheless, 20 to
0% of patients with chronic heart failure have AF [7,8],
ndicating that this is a common ﬁnding in these patients.
mong the various diastolic variables, an early-to-late ﬁlling
elocity ratio greater than 2 (E/A ratio) and a short deceler-
tion time of early transmitral ﬁlling are clearly recognized
s powerful predictors of poor prognosis in heart-failure
atients with LV systolic dysfunction and SR [1—6].
Given the high incidence of AF among patients with
V systolic dysfunction, it would be useful to determine
hether pulsed-wave Doppler recording of mitral inﬂow
ould also provide prognostic information, even in the pres-
nce of AF. Indeed, very little information is available on
iastolic ﬁlling and outcome of heart-failure patients with LV
ystolic dysfunction and AF [7,8]. Because of the monophasic
wave resulting from the AF state, the deceleration time of
itral inﬂow E velocity (E-wave DT) could be used to analyse
•
w
prythme sinusal qu’en ﬁbrillation auriculaire.
sson SAS.
he prognostic value in heart-failure patients with LV sys-
olic dysfunction and AF. To test this hypothesis, we decided
o assess whether a short deceleration time of the E wave
ecorded in heart-failure patients with LV systolic dysfunc-
ion could predict a poor prognosis even in the presence of
F. The objective of this prospective study was also to com-
are the prognostic value of this Doppler index in patients
n AF with those of patients in SR.
ethods
atients
e prospectively included, between February 1996 and
ovember 1998, consecutive patients hospitalised with
linical congestive heart failure (CHF) and LV systolic dys-
unction. The inclusion criteria were as follows:
LV ejection fraction less than 40% on echocardiographic
examination;
absence of valvular heart disease;
absence of a permanent pacemaker;
clinical stability for at least three weeks;
acceptable acoustic window.
Patients with chronic AF (i.e., greater than one month)
ere documented by previous electrocardiogram. All
















































ODeceleration time and atrial ﬁbrillation
Echocardiographic examination
All echocardiographic measurements were performed after
three weeks of clinical stability following an episode of con-
gestive heart failure and under optimal therapy. All studies
were analysed without knowledge of the clinical data. Entire
echocardiography and Doppler examination were completed
for each patient (Sonos 2000 or 5500, Philips Ultrasound sys-
tem, probe 2.5MHz), including measurements of LV diastolic
and systolic diameters and LV diastolic and systolic volumes
using the biplane Simpson’s method. LV ejection fraction and
shortening fraction were calculated. Tricuspid regurgitation
was recorded and pulmonary systolic-artery pressure cal-
culated. Mitral-ﬂow velocity was assessed by pulsed-wave
Doppler echocardiography in the apical four-chamber view
with the sample volume placed between the tips of the
mitral leaﬂets, where maximal ﬂow velocity was recorded
[9]. The peak velocities of the early ﬁlling (E) wave and the
atrial contraction (A) wave were measured and their ratio
(E/A) was calculated in patients with SR. The E-wave DT was
calculated as the time between peak E wave and the upper
deceleration slope by extrapolation to the zero baseline.
For all measurements of Doppler variables, ﬁve to 10 con-
secutive beats were analysed and averaged. Mitral-Doppler
tracings of sufﬁcient quality were obtained in all patients.
Follow-up data
For evaluation of clinical outcome, the follow-up period was
deﬁned as beginning on the day after echocardiographic
examination. The major endpoint was total mortality.
Follow-up information was obtained from the review of visit
and hospital records, when available, or by direct mail ques-
tionnaire or by telephone contact with the patients, their
relatives or physicians regarding death, cardiac (sudden
death, progressive pump failure, cardiac transplantation)
and noncardiac.
Statistical analysis
Results are presented as mean plus or minus standard
deviation (S.D.). A two-sample t test was performed to com-
pare continuous variables. The chi-square test was used
to compare categorical variables (with Yates’ correction or
Fisher’s exact test, as appropriate, in smaller sample size).
The Kaplan—Meier method was used for cumulative sur-
vival analysis with the log-rank test for assessing statistical
differences between curves. E-wave DT, considered as a con-
tinuous value, was also treated as a dichotomous variable
with an arbitrarily chosen cut-off of 150ms corresponding
to the value considered in clinical practice that could best
discriminate between the two groups of patients [1,10,11].
The clinical, echocardiographic and Doppler variables were
compared regarding prognostic signiﬁcance for predicting
mortality using the Cox proportional-hazards model. Base-
line variables that had an association with mortality at a p
value less than 0.05 by univariate analyses were included
in the multivariable Cox model, selected according to a
backward stepwise selection process and entered into or
removed from the regression equation on the basis of a com-
puted signiﬁcance probability value. A p value less than 0.05





ogether with odds-ratios (ORs) are given for the multivari-
ble Cox models.
eproducibility
he reproducibility of E-wave DT measurement was assessed
n 30 randomly selected patients. To test intra- and
nterobserver variability, the same examiner and another
ndependent observer measured mitral ﬂow on videotape
hat contained selected beats. Intra- and interobserver
ariations were assessed as the mean± 1 S.D. differ-
nce between the two sets of observations. Mean percent
rror was calculated as the absolute difference divided by
he average of the two observations. In addition, Kappa
tatistics were used to determine intra- and interobserver




he study population comprised 140 patients with a mean
ge of 65± 11 years (115 men, 25 women). One hundred
71%) patients were in SR (21 women, 79 men), with a
ean age of 65± 11 years and 40 (29%) were in AF (four
omen, 36 men), with a mean age of 68± 12 years (p = 0.08).
ean LV ejection fraction was of 33± 7%. The baseline
linical, mode-M and Doppler echocardiographic, aetiolog-
cal and therapeutic characteristics of study patients are
ummarized in Table 1. Underlying diagnoses and use of
harmacological medications, except for digoxin and amio-
arone, were similar in patients with AF and in patients
ith SR. Echocardiographic LV diameters in the AF group
ere slightly lower than those in the SR group. Conversely,
eft and right atrial areas were higher in the AF group.
ean E-wave DT was 169± 64ms in the global population.
n the AF group, E-wave DT was lower (150± 48ms ver-
us 176± 68ms; p = 0.05) and peak E velocity signiﬁcantly
igher than in the SR group (102± 30ms versus 77± 24ms;
< 0.0001).
aseline clinical and Doppler
chocardiographic variables according to
-wave DT
mong the 76 patients with an E-wave DT less or equal to
50ms, 25 (33%) were in AF and 51 (67%) in SR. The uni-
ariate analysis of clinical and Doppler echocardiographic
ariables stratiﬁed according to rhythm and related to E-
ave DT are shown in Tables 2 and 3. Multivariable logistic
egression analysis revealed that systolic pulmonary arterial
ressure and E-wave peak velocity were the only indepen-
ent markers of E-wave DT less or equal to 150ms.
verall survival rateshe mean follow-up duration of the entire patient cohort
as 25± 11 months (range: 1 to 48). No patient was lost
o follow-up. Patients in the SR group were followed for
mean of 24± 10 months and those in the AF group for
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Table 1 Comparison of baseline characteristics for the sinus rhythm and atrial ﬁbrillation groups.
Total group (n = 140) Patient in SR (n = 100) Patient in AF (n = 40)
Clinical data
Age (years) 66± 11 65± 11 68± 12
Men 115 (82%) 79 (79%) 36 (90%)
NYHA class III—IV 111 (78%) 77 (77%) 34 (85%)
HR (beats/min) 79± 17 80± 15 77± 21
SBP (mmHg) 133± 23 131± 23 137± 25
Aetiology
CAD 93 (66%) 65 (65%) 28 (70%)
IDC 42 (30%) 34 (34%) 10 (25%)
Other 3 (3%) 1 (1%) 2 (5%)
Medication
Diuretics 137 (98%) 97 (97%) 40 (100%)
ACE inhibitors 130 (93%) 92 (92%) 38 (95%)
Cardiac digitalis 63 (45%) 38 (38%) 25 (63%)**
Echocardiographic data
LVEDDI (cm/m2) 3.6± 0.6 3.6± 0.5 3.4± 0.5*
LVESDI (cm/m2) 2.9± 0.5 2.9± 0.5 2.7± 0.5*
SF (%) 20± 6 19± 6 20± 6
LVEDVI (mL/m2) 106± 29 107± 28 105± 31
LVESVI (mL/m2) 73± 24 72± 22 74± 47
LVEF (%) 31± 8 32± 0.5 31± 8
LAA (cm2) 27± 6 25± 5 30± 5***
RAA (cm2) 20± 8 17± 5 25± 8***
SPAP (mmHg) 39± 11 38± 12 41± 9
Peak E velocity (cm/s) 84± 29 77± 24 102± 30***
E-wave DT (ms) 169± 64 176± 68 150± 48*
Data are presented as the mean value or percentage of patients: SR: sinus rhythm; AF: atrial ﬁbrillation; HR: heart rate; NYHA: New York
Heart Association; SBP: systolic blood pressure; CAD: coronary-artery disease; IDC: idiopathic cardiomyopathy; LVEF: left-ventricular
ejection fraction; LVEDDI: left-ventricular end-diastolic diameter index; LVESDI: left-ventricular end-systolic diameter index; SF:
shortening fraction; LVEDVI: left-ventricular end-diastolic volume index; LVESVI: left-ventricular end-systolic volume index; LVEF:
left-ventricular ejection fraction; SPAP: systolic-pulmonary arterial pressure; E-wave DT: E-wave deceleration time.
* p < 0.05.
** p < 0.001.






























n9± 13 months. During the entire follow-up, 54 (39%) deaths
ccurred: 36 (36%) in the SR group and 18 (45%) in the AF
roup. Forty-nine patients died of cardiac causes (35%): sud-
en death in 18 cases, refractory heart failure in 31 cases
nd cardiac transplantation in one case. Among the ﬁve non-
ardiac deaths, one patient was in AF.
The estimated one- and two-years survival rates for the
ntire patient cohort were 91 and 77%, respectively. Sur-
ival rates did not differ signiﬁcantly between the AF and
R groups (p = 0.89), with the respective one- and two-years
urvival rates of 87 and 74% in the AF group, compared
ith 85 and 75% in the SR group. Patients with an E-wave
T less or equal to 150ms from the entire patient cohort
ad a poor prognosis compared with those with an E-wave
T greater than 150ms (p < 0.0001). The respective one-
nd two-years survival rates were 77 and 60% for patients
ith E-wave DT less or equal to 150ms versus 95 and 92%
or patients with a E-wave DT greater than 150ms. When





nroups (in SR and in AF) with a E-wave DT less or equal to
50ms had a poor outcome compared with the two other
atient groups with a E-wave DT greater than 150ms. The
umulative mortality rates for both patient groups in AF and
R with E-wave DT less or equal to and greater than 150ms
etermined by the Kaplan—Meier method are depicted in the
ig. 1.
redictors of survival by univariate analysis
he inﬂuence of baseline variables on survival in the entire
ohort and in the AF and SR groups is shown in Table 4.
imilarly to other groups, survival in AF group was sig-
iﬁcantly lower in patients with shortened E-wave DT.
n addition, decreased systolic-blood pressure, increased
V end-diastolic diameter and volume, increased LV end-
ystolic diameter and volume and decreased shortening
raction and LV ejection fraction were found to have a sig-
iﬁcant inﬂuence.
Deceleration time and atrial ﬁbrillation 321
Table 2 Clinical and Doppler echocardiographic char-









Age (years) 68± 13 67± 11
Men 23 (92%) 13 (87%)
NYHA class III—IV 21 (84%) 13 (87%)
HR (beats/min) 76± 24 79± 16
SBP (mmHg) 136± 25 138± 24
Doppler echodata
LVEDDI (cm/m2) 3.5± 0.5 3.4± 0.5
LVESDI (cm/m2) 2.8± 0.5 2.7± 0.4
SF (%) 21± 6 19± 5
LVEDVI (mL/m2) 104± 32 105± 31
LVESVI (mL/m2) 73± 48 75± 38
LVEF (%) 30± 7 32± 8
LAA (cm2) 29± 6 31± 6
RAA (cm2) 23± 8 26± 6
SPAP (mmHg) 42± 11 39± 8
Peak E velocity (cm/s) 103± 33 101± 29
Abbreviations as in Table 1.
Table 3 Clinical and Doppler echocardiographic char-









Age (years) 65± 13 66± 11
Men 42 (82%) 37 (76%)
NYHA class III-IV 39 (76%) 38 (78%)
HR (beats/min) 82± 19 79± 20
SBP (mmHg) 131± 18 132± 22
Doppler echodata
LVEDDI (cm/m2) 3.8± 0.5 3.5± 0.3
LVESDI (cm/m2) 3.0± 0.2 2.9± 0.1
SF (%) 20± 5 19± 5 †
LVEDVI (mL/m2) 108± 27 106± 30
LVESVI (mL/m2) 73± 26 71± 10
LVEF (%) 33± 7 30± 8
LAA (cm2) 26± 3 25± 8
RAA (cm2) 16± 8 18± 6
SPAP (mmHg) 37± 11 40± 9
Peak E velocity (cm/s) 80± 24 75± 28
Abbreviations as in Table 1.
Figure 1. Kaplan—Meier survival curves for patients with atrial























gime. Both patient groups with E-wave DT < 150ms (dashed line)
ad a signiﬁcantly lower survival rate than those with a DT≥150ms
solid line).
redictors of survival by multivariable analysis
ariables signiﬁcant by multivariable analysis using Cox
egression in a backward stepwise procedure for survival
ree of deaths are shown in Table 5. In the multivariable
nalysis performed in all patients with LV systolic dys-
unction, the independent determinants of survival were a
hortened E-wave DT (p < 0.0001), a decreased LV ejection
raction (p = 0.002), a decrease in systolic-blood pressure
p = 0.01) and a functional class III or IV (p = 0.01). In addi-
ion, a shortened E-wave DT was also identiﬁed as a strong
egative predictor of survival in the AF group (p = 0.02) as in
he SR group (p = 0.002).
eproducibility
ntra- and interobserver variations were 2± 11 and
± 12ms, respectively, with mean percent errors of 6% for
he same observer and of 9% between the two observers. The
ntra- and interobserver concordances for predicting E-wave
T less or equal to 150ms were 95% (kappa: 0.89) and 94%
kappa: 0.87), respectively. In 10 randomly patients from AF
roup, intra- and interobserver concordances for predicting
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Table 4 Univariate analysis: predictors of fatal outcome.
Total group Sinus rhythm Atrial ﬁbrillation
Chi-square p value Chi-square p value Chi-square p value
Clinical data
Age (years) 4.72 0.03 5.73 0.017 0.55 0.46
Women 0.30 0.29 0.50 0.48 0.02 0.89
NYHA class III—IV 11.62 < 0.001 12.95 < 0.001 0.70 0.40
HR 0.23 0.63 0.28 0.60 0.99 0.32
SBP 13.39 < 0.001 5.30 0.02 6.74 < 0.01
Echodata
LVEDDI 5.54 0.02 0.20 0.65 12.36 < 0.001
LVESDI 14.40 0.001 1.05 0.31 15.95 < 0.0001
SF 3.31 0.07 2.51 0.11 12.19 < 0.001
LVEDVI 2.12 0.15 0.002 0.96 4.68 0.03
LVESVI 8.29 < 0.01 1.27 0.26 8.42 0.004
LVEF 20.84 < 0.0001 11.42 < 0.001 10.20 0.001
LAA 0.11 0.75 0.03 0.86 2.35 0.12
RAA 1.19 0.28 1.76 0.18 1.38 0.23
SPAP 7.02 0.01 15.27 < 0.0001 0.38 0.54
Mitral Doppler data
Peak E velocity 0.36 0.55 2.90 0.09 0.11 0.75
Peak A velocity NA NA 5.99 0.01 NA NA
E/A ratio NA NA 5.67 0.02 NA NA
E-wave DT 24.26 < 0.0001 14.83 0.0001 10.11 0.002
NA= not applicable; other abbreviations as in Table 1.
Table 5 Independent predictors of fatal outcome (multivariable Cox-proportional hazard models).
Variable Beta-coefﬁcient Chi-square p value Exponential of coefﬁcient
In all patients with LV systolic dysfunction
NYHA class III—IV − 1.86 6.51 0.01 0.16
SBP (mmHg) − 0.02 6.32 0.01 0.99
LVEF (%) − 0.06 10.11 0.002 0.94
E-wave DT (ms) − 0.02 15.34 < 0.0001 0.99
In patients with LV systolic dysfunction and sinus rhythm
Age (years) 0.03 3.93 < 0.05 1.03
SBP (mmHg) − 0.01 4.36 0.04 0.99
SPAP (mmHg) 0.04 4.46 0.03 1.04
NYHA class III—IV − 2.32 5.13 0.02 0.10
E-wave DT (ms) − 0.01 9.62 0.002 0.99
In patients with LV systolic dysfunction and atrial ﬁbrillation













pLVEF (%) − 0.13 9.9
E-wave DT (ms) − 0.03 5.8
-wave DT less or equal to 150ms were 93% (kappa: 0.88)
nd 92% (kappa: 0.84), respectively.
iscussionhe present prospective study demonstrates that the
-wave DT, assessed by Doppler, is a reproducible, useful
nd reliable noninvasive tool for predicting the prognosis of





ven in the presence of AF. Speciﬁcally, we showed that a
hortened E-wave DT (≤ 150ms) as an index of LV diastolic
estrictive ﬁlling could predict a similar poor outcome in
atients with AF as with SR.elation of E-wave DT to ﬁlling pressure
everal haemodynamic studies have demonstrated the























































cDeceleration time and atrial ﬁbrillation
in patients with LV systolic dysfunction [12—15]. As ﬁll-
ing pressure increases, the nondistensible ventricle may
induce a more rapid increase in diastolic pressure with a
faster equilibration of left atrial and LV pressures, resulting
in premature cessation of mitral ﬂow and a short decel-
eration time of early ﬁlling [16]. These haemodynamic
studies have clearly demonstrated a close negative cor-
relation between deceleration time of early ﬁlling and
pulmonary-artery wedge pressure in patients with LV sys-
tolic dysfunction and SR [14,15]. In two previous studies
conducted in patients in chronic AF with ischaemic or
idiopathic-dilated dilated cardiomyopathy [16,17], E-wave
DT was signiﬁcantly and inversely related to mean pul-
monary wedge pressure. Moreover, Temporelli et al. found
that E-wave DT was identiﬁed as the sole independent pre-
dictor of pulmonary-wedge pressure and that a shortened DT
less or equal to 120ms reliably predicted a marked elevated
pulmonary-wedge pressure (≥ 20mmHg) with sensitivity and
speciﬁcity of 100 and 96%, respectively [16]. Other studies
[18,19] found a weak relation in general between deceler-
ation time and pulmonary-wedge pressure in the presence
of AF. However, patients who were included in these later
studies had both depressed or preserved LV systolic func-
tion with a wide variety of heart diseases. The fact that
E-wave DT does not related to LV ﬁlling pressures in patients
in SR with diastolic dysfunction secondary to hypertrophy or
ischaemic heart disease and preserved LV systolic function
may account for this discrepancy [13,14,20]. Furthermore,
Nagueh et al. showed that the relation between E-wave
DT and pulmonary-wedge pressure depended on the level
of LV systolic function in patients with AF [19]. In the
group of patients with depressed ejection fraction (< 45%),
a good relation was observed between deceleration time
and pulmonary-wedge pressure (R =− 0.78), whereas in the
subgroup with preserved systolic function, no relation was
found. This is not surprising since one would expect that
even in AF early diastolic LV ﬁlling velocities are governed
by the same interactions between LV and atrial pressures
operating with SR [17].
Prognostic implication of shortened
Doppler-derived E-wave DT
Others and we had shown that Doppler-derived mitral ﬂow
variables are important indicators of mortality and wors-
ening heart failure in various cardiac diseases [1—6,10].
In the majority of previous studies carried with either
ischaemic or idiopathic dilated cardiomyopathy, restric-
tive mitral ﬂow was independently associated with poor
prognosis [1—6]. However, these studies were performed
exclusively in patients with SR, so their results could not be
applied to patients with LV systolic dysfunction in the pres-
ence of AF. The present study, to our knowledge, is the ﬁrst
to demonstrate that Doppler-derived LV ﬁlling, speciﬁcally
the short mitral deceleration time, is a powerful indepen-
dent predictor of fatal outcome in heart-failure patients due
to LV systolic dysfunction even in presence of AF.
Atrial ﬁbrillation is common in patients with advanced
chronic-heart failure, but data regarding its clinical and
prognostic signiﬁcance are inconclusive [8,21—25]. In our





ently associated with adverse outcome in this population.
lthough limited by the relatively small patient group, our
esults are consistent with large series of patients with
dvanced chronic-heart failure and AF showing no differ-
nce in prognosis between AF and SR [23,24]. These ﬁndings
uggest that factors associated with chronic-heart failure
r caused by AF may play a prognostic role in heart-failure
atients with LV systolic dysfunction in AF. In the present
tudy, a short E-wave DT was not only identiﬁed as indepen-
ent predictor of a poor prognosis in heart-failure patients
ith LV systolic dysfunction and SR, but was also indepen-
ently associated with an adverse prognosis in the presence
f AF. To date, the prognostic implication of diastolic abnor-
alities in AF has been poorly investigated. Only one study
xamined the prognostic value of restrictive ﬁlling pattern in
atients with AF. In this retrospective series, with a median
ollow-up of 2.2 years, Hurrell et al. showed that a short-
ned mitral DT less or equal to 130ms predicted a similar
oor prognosis in patients with AF as with SR [26]. However,
atients of this study were selected for a very short E-wave
T and had a wide range of cardiac diseases with both nor-
al and depressed ejection fractions. In the present study,
e enrolled prospectively patients only on the basis of LV
ystolic function, irrespective of rhythm itself with a wide
ange of E-wave DT. Our ﬁndings indicate that a shortened
itral deceleration time appears to provide a poor progno-
is in LV systolic dysfunction independently of rhythm itself,
ith a similar risk for patients with AF as with SR. Thus,
t is reasonable to speculate that an increase in chamber
tiffness due to extensive scarring and structural changes of
yocardial tissue, accompanied by an increase in LV ﬁlling
ressures and left-atrial pressures (as mentioned above in
aemodynamic studies) is the most likely underlying mech-
nism of restrictive ﬁlling in patients with AF as with SR.
owever, it is well recognized that AF itself may lead to
athological and haemodynamic changes. These changes are
aused by the loss of atrial contraction, irregular ventricu-
ar ﬁlling and inappropriately high heart rates, particularly
uring exercise. As a result, LV ejection, exercise capac-
ty and peripheral ﬂow decrease, leading to an increase in
igns and symptoms as a worse NYHA functional class or a
ecrease in blood pressure. Therefore, it was not surprising
hat we identiﬁed a low ejection fraction and a decrease
n blood pressure as being independently associated with
dverse outcome in the group of patients with LV systolic
ysfunction and AF.
tudy limitations
his study has several potential limitations. Multiple factors
an inﬂuence LV diastolic ﬁlling variables [27—29], including
he aging process, loading conditions, valvular regurgitation,
eart rate and beat-to-beat variability. Our study was per-
ormed in a selected population of heart-failure patients
ith LV ejection fraction less than 40% without associated
alvular regurgitation, in whom adequate ventricular-rate
ontrol had been obtained. Thus, the results of the cur-
ent study cannot be generalized to other patients, in
articular to those with preserved LV systolic function in
R or AF.
Age may have been unlikely to have a signiﬁcant impact



































































lder. Indeed, age was not independently related to either
-wave DT or adverse prognosis. No signiﬁcant difference in
eart rate was found between our two groups of patients
ith SR and AF or between those with E-wave DT less or
qual to and greater than 150ms. The loading conditions
f patients were not characterized in this study, but might
ave been inﬂuenced by patients’ medications. However,
he distribution of diuretic agents, angiotensin-converting
nzyme inhibitors and nitrates was similar between the two
roups of patients with SR and AF as between the two
roups with E-wave DT less or equal to and greater than
50ms.
Pulmonary venous ﬂow Doppler was not examined in
ur study, which may have enhanced the ability to identify
estrictive LV ﬁlling in patients with AF [17,18]. However, use
lone of pulmonary venous-ﬂow parameters may not be as
redictive in AF as in SR [17,18,30]. The peak acceleration
f mitral velocity and isovolumic relaxation time may also
rovide additional useful information [17,19]. We did not
lso consider other diastolic function indices as derived from
issue Doppler of mitral annulus or colour M-mode Doppler
f mitral inﬂow because these relatively recent methods
ere not routinely performed at the outset of our study.
owever, the aim of this study was to investigate whether
nalysis of only mitral ﬂow velocity proﬁle, which is easy to
btain in all patients and is extensively used in the nonin-
asive assessment of LV ﬁlling abnormalities, would provide
ccurate prognostic information in patients with LV systolic
ysfunction with SR as with AF.
Furthermore, AF is associated with changing diastolic
ime intervals that could make it difﬁcult to analyse the
aemodynamics of LV ﬁlling. Nagueh et al. demonstrated
ess variability of E velocities and deceleration time between
ifferent cardiac cycles in patients with increased LV ﬁlling
ressures (> 15mmHg) than in those with lower pressures
19]. To minimize variation in cardiac cycles, our echocar-
iographic studies were performed after three weeks of
linical stability under optimal therapy, such that the length
f diastole should remain the most stable when recording
eceleration time. It should also be noted that the use of
single Doppler echocardiographic study to assess prog-
osis has limitations because LV diastolic ﬁlling velocity
roﬁle may change over time with long-term medical treat-
ent. Therefore, further studies involving larger numbers
f patients with serial Doppler echocardiographic follow-up
re required to better understand the mechanisms involved
n diastolic changes affecting the prognosis of patients with
V poor systolic function and AF.
onclusions
espite the limitations discussed above, the present data
how that mitral E-wave DT recorded by Doppler echocar-
iography can provide valuable prognostic information in
eart-failure patients with ventricular systolic dysfunction,
ven in the presence of AF. Deﬁned as an index of restric-
ive ﬁlling, a shortened mitral DT appears to predict a similar
oor prognosis in LV systolic dysfunction with AF as with SR.
ecause the determination of mitral E-wave DT is feasible,
eproducible and accurate in the presence of AF, it should
e included deﬁnitively in the noninvasive prognostic evalu-
[M. Peltier et al.
tion of all patients with LV systolic dysfunction, irrespective
f the underlying rhythm.
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